Synapse - Jason Konner

Results (156)

Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for advanced ovarian cancer

Meeting Abstract

Tanner, E.; Dao, F.; Zivanovic, O.; Kehoe, S.; Black, D.; Konner, J.; Barakat, R.; Lichtman, S.; Levine, D.
Gynecologic Oncology (2010)

Fulltext@MSK | Save

Analysis of progression-free survival, tolerability and toxicity in patients with stage III ovarian, tubal and peritoneal carcinoma treated with an outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin

Meeting Abstract

Chi, D.; Dao, F.; Ferguson, S.; Sabbatini, P.; Hensley, M.; Konner, J.; Tew, W.; Bell-Mcguinn, K.; Barakat, R.; Aghajanian, C.
Gynecologic Oncology (2010)

Fulltext@MSK | Save

Consolidation strategies in ovarian cancer: Observations for future clinical trials

Journal Article

Sabbatini, P.; Spriggs, D.; Aghajanian, C.; Hensley, M.; Tew, W.; Konner, J.; Bell-Mcguinn, K.; Juretzka, M.; Iasonos, A.
Gynecologic Oncology (2010)

Fulltext@MSK | Save

Farletuzumab, a humanized monoclonal antibody against folate receptor α, in epithelial ovarian cancer: A phase I study

Journal Article

Konner, J. A.; Bell-Mcguinn, K. M.; Sabbatini, P.; Hensley, M. L.; Tew, W. P.; Pandit-Taskar, N.; Vander Els, N.; Phillips, M. D.; Schweizer, C.; Weil, S. C.; more...
Clinical Cancer Research (2010)

Fulltext@MSK | Save

Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinoma

Journal Article

Diaz, J. P.; Tew, W. P.; Zivanovic, O.; Konner, J.; Sabbatini, P. J.; dos Santos, L. A. ; Abu-Rustum, N. R.; Chi, D. S.; Aghajanian, C.; Barakat, R. R.
Gynecologic Oncology (2010)

Fulltext@MSK | Save

Intraperitoneal chemotherapy (IPC) in older women with epithelial ovarian cancer (EOC)

Meeting Abstract

Tew, W. P.; O'Cearbhaill, R.; Zhou, Q.; Thaler, H.; Konner, J.; Hensley, M. L.; Sabbatini, P.; Spriggs, D.; Aghajanian, C.; Lichtman, S. M.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel, IP cisplatin, and IV bevacizumab as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer

Meeting Abstract

Konner, J. A.; Grabon, D.; Pezzulli, S.; Iasonos, A.; Sabbatini, P.; Hensley, M.; Bell-McGuinn, K.; Tew, W.; Spriggs, D.; Aghajanian, C.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Haplotype analysis of bevacizumab-induced hypertension

Meeting Abstract

Frey, M. K.; Olvera, N.; Bogomolniy, F.; Dao, F.; Borsu, L.; Konner, J.; Barakat, R. R.; Dickler, M.; Levine, D. A.
Gynecologic Oncology (2009)

Fulltext@MSK | Save

Incidence and management of bevacizumab-associated gastrointestinal perforation in patients with recurrent ovarian carcinoma

Meeting Abstract

Diaz, J. P.; Zivanovic, O.; Tew, W. P.; Konner, J.; Sabbatini, P. J.; Chi, D. S.; Aghajanian, C.; Barakat, R. R.
Gynecologic Oncology (2009)

Fulltext@MSK | Save

Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy

Journal Article

Zivanovic, O.; Leitao, M. M. Jr; Park, K. J.; Zhao, H.; Diaz, J. P.; Konner, J.; Alektiar, K.; Chi, D. S.; Abu-Rustum, N. R.; Aghajanian, C.
Gynecologic Oncology (2009)

Fulltext@MSK | Save